Reply to Letter to the Editor of Dr. Sitkin et al., Regarding "Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome is Another Key to the Pathogenesis of Inflammatory Bowel Disease"

Inflamm Bowel Dis. 2019 Nov 14;25(12):e159. doi: 10.1093/ibd/izz230.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Child
  • Colitis, Ulcerative*
  • Crohn Disease*
  • Gastrointestinal Microbiome*
  • Humans
  • Inflammatory Bowel Diseases*
  • Metabolomics
  • Sphingolipids

Substances

  • Sphingolipids